• Correction to: ¡°Cardiovascular Outcomes Comparison of Dipeptidyl Peptidase-4 Inhibitors Versus Sulf...

• Jeon Won-Kyeong

• Kang Jee-Hoon, Kim Hyo-Soo, Park Kyung-Woo

• ÁöÁú.µ¿¸Æ°æÈ­ÇÐȸÁö   2022  Volume.11  No.1 89 ~ 101

• Response to Letter Regarding Article, ¡°Cardiovascular Outcomes Comparison of Dipeptidyl Peptidase-4...

• Park Kyung-Woo

• ÁöÁú.µ¿¸Æ°æÈ­ÇÐȸÁö   2022  Volume.11  No.1 87 ~ 88

• Letter by Awadhesh Kumar Singh Regarding Article, ¡°Cardiovascular Outcomes Comparison of Dipeptidyl...

• Singh Awadhesh Kumar

• Singh Ritu

• ÁöÁú.µ¿¸Æ°æÈ­ÇÐȸÁö   2022  Volume.11  No.1 84 ~ 86

• Assessing the Validity of the Criteria for the Extreme Risk Category of Atherosclerotic Cardiovascul...

• Kim Kyung-Soo

• Hong Sang-Mo, Han Kyung-Do, Park Cheol-Young

• ÁöÁú.µ¿¸Æ°æÈ­ÇÐȸÁö   2022  Volume.11  No.1 73 ~ 83

• Profiling of RNA-binding Proteins Interacting With Glucagon and Adipokinetic Hormone mRNAs

• Ko Seung-Beom

• Yeom Eun-Byul, Chun Yoo-Lim, Mun Hye-Jin, Howard-McGuire Marina, Millison Nathan T., Jung Jun-Y...

• ÁöÁú.µ¿¸Æ°æÈ­ÇÐȸÁö   2022  Volume.11  No.1 55 ~ 72

• Individualized Treatment for Patients With Familial Hypercholesterolemia

• Tada Hayato

• Takamura Masayuki, Kawashiri Masa-aki

• ÁöÁú.µ¿¸Æ°æÈ­ÇÐȸÁö   2022  Volume.11  No.1 39 ~ 54

• Metabolism and Health Impacts of Dietary Sugars

• Alam Yasmine Henna

• Kim Raymond, Jang Chol-Soon

• ÁöÁú.µ¿¸Æ°æÈ­ÇÐȸÁö   2022  Volume.11  No.1 20 ~ 38

• SGLT2 Inhibitors and Ketone Metabolism in Heart Failure

• Saucedo-Orozco Huitzilihuitl

• Voorrips Suzanne N., Yurista Salva R., de Boer Rudolf A., Westenbrink B. Daan

• ÁöÁú.µ¿¸Æ°æÈ­ÇÐȸÁö   2022  Volume.11  No.1 1 ~ 19